Who owns TRAVERE THERAPEUTICS INC?
- CUSIP Number: 89422g907
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jpmorgan Chase & Co | 445k | $11M | 4348% | Sep 2025 |
|
| Simplex Trading | 208k | $5.0M | 85% | Sep 2025 |
|
| Exome Asset Management | 110k | $2.6M | 0% | Sep 2025 |
|
| IMC-Chicago | 63k | $1.5M | 100% | Sep 2025 |
|
| Group One Trading | 56k | $1.3M | -78% | Sep 2025 |
|